Core Informatics and OpenEye Scientific Software forge partnership

Core Informatics and OpenEye Scientific Software announce partnership and their integration of OpenEye cheminformatics software into Core Informatics’ web-based Laboratory Information Management System and Electronic Lab Notebook

BRANFORD, Conn.—Core Informatics, a provider of datamanagement solutions to the life sciences, molecular diagnostics and energyindustries, and OpenEye Scientific Software, a developer of innovativemolecular modeling and cheminformatics solutions for molecular discovery, inearly April announced a partnership and the integration of OpenEye cheminformaticssoftware into Core Informatics' web-based Laboratory Information ManagementSystem (Core LIMS) and Electronic Lab Notebook (Core ELN).
 
 
The Core LIMS and Core ELN offer a wide array of featuresthrough a flexible component-based architecture that provides organizationswith individually tailored data management solutions. Core Informatics'introduction of an OpenEye powered Chemical Registration Application enablesuser access to the robust chemistry handling processes available in OpenEye's cheminformaticssuite within the Core LIMS.
 
 
OpenEye's focus on quality chemistry, speed and dataintegrity enable performance in capabilities such as compound registration,unique compound identification, search and retrieval of exact and similarmolecules, enhanced structure visualization and reaction handling. Examples ofthis focus include use of canonical isomeric SMILES to uniquely identifycompounds, multiple language translation and a curated set of useful calculatedproperties.
 
 
"Our partnership with OpenEye exemplifies Core Informatics'desire to provide our client base access to an expanding array ofcheminformatics tools," said Anthony Uzzo, President of Core Informatics, in astatement. "We are additionally enthusiastic to draw upon OpenEye's unparalleledexpertise in 3D molecular shape and electrostatics as future extensions to theCore LIMS."
 
 
"We are thrilled that users of the Core platform will haveaccess to all the great cheminformatics developed at OpenEye," added AnthonyNicholls, CEO and founder of OpenEye. "It has always been our 'core' mission tosupply the chemistry community with the very best and most innovative softwarepossible, and this partnership with Core is a big step towards that goal."
 


Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

November 2022 Issue Front Cover

Latest Issue  

• Volume 18 • Issue 11 • November 2022

November 2022

November 2022